OnKure Therapeutics, Inc. OKUR Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 13.8×+3.5× | 10.3×-1.2× | 11.4×+0.3× | 11.1×0.0× | 11.2×+0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $13.48+224% | $4.16-15.3% | $4.91-15.2% | $5.79-14.3% | $6.75-77.6% | |
| Valuation | ||||||
| Market capitalization | $184.2M+72.6% | $123.71M+5.6% | $117.16M— | —— | —— | |
| Price / book | 1×-0.4× | 2.2×+0.4× | 1.8×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do OnKure Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from OnKure Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.